Using the Analytic Hierarchy Process to Elicit Patient Preferences

[1]  Luis G. Vargas,et al.  Decision Making with the Analytic Network Process: Economic, Political, Social and Technological Applications with Benefits, Opportunities, Costs and Risks , 2013 .

[2]  Maarten Joost IJzerman,et al.  A Comparison of Analytic Hierarchy Process and Conjoint Analysis Methods in Assessing Treatment Alternatives for Stroke Rehabilitation , 2012, The Patient - Patient-Centered Outcomes Research.

[3]  Maarten J. IJzerman,et al.  Integrating patients' views into health technology assessment: Analytic hierarchy process (AHP) as a method to elicit patient preferences , 2011, International Journal of Technology Assessment in Health Care.

[4]  Maarten J. IJzerman,et al.  Assessment of the added value of the Twente Photoacoustic Mammoscope in breast cancer diagnosis , 2011, Medical devices.

[5]  Marjukka Mäkelä,et al.  Volume 26: Statistics and thanks , 2011, International Journal of Technology Assessment in Health Care.

[6]  J. Dolan.  Multi-criteria clinical decision support: A primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare , 2011 .

[7]  J. Baron,et al.  Towards Patient-Centered Care for Depression , 2012 .

[8]  C. Dowrick,et al.  Impact of severity and type of depression on quality of life in cases identified in the community , 2010, Psychological Medicine.

[9]  P. Gøtzsche,et al.  Antidepressant Drug Effects and Depression Severity: A , 2010 .

[10]  J. Baron,et al.  TOWARDS PATIENT-CENTERED CARE FOR DEPRESSION: CONJOINT METHODS TO TAILOR TREATMENT BASED ON PREFERENCES. , 2010, The patient.

[11]  J. Dolan.  Multi-Criteria Clinical Decision Support , 2010, The patient.

[12]  B. Gaynes,et al.  Screening for Depression in Adult Patients in Primary Care Settings: A Systematic Evidence Review , 2009, Annals of Internal Medicine.

[13]  Emily Lancsar,et al.  Choice experiments in health: the good, the bad, the ugly and toward a brighter future , 2009, Health Economics, Policy and Law.

[14]  V. Milanova,et al.  Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR , 2009, Journal of psychopharmacology.

[15]  Matthew J. Liberatore,et al.  The analytic hierarchy process in medical and health care decision making: A literature review , 2008, Eur. J. Oper. Res..

[16]  C. Sherbourne,et al.  Treatment preferences among depressed primary care patients , 2000, Journal of General Internal Medicine.

[17]  N. Powe,et al.  Identification of patient attitudes and preferences regarding treatment of depression , 1997, Journal of General Internal Medicine.

[18]  James C. Dolan,et al.  Diagnostic strategies in the management of acute upper gastrointestinal bleeding , 1993, Journal of General Internal Medicine.

[19]  Emily Lancsar,et al.  Deleting 'irrational' responses from discrete choice experiments: a case of investigating or imposing preferences? , 2006, Health economics.

[20]  A. Schatzberg,et al.  Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. , 2005, Journal of psychiatric research.

[21]  B. Bloom.  Prevalence and economic effects of depression. , 2004, Managed care.

[22]  John F P Bridges,et al.  Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. , 2003, Applied health economics and health policy.

[23]  P. Masand,et al.  Long-Term Side Effects of Newer-Generation Antidepressants: SSRIS, Venlafaxine, Nefazodone, Bupropion, and Mirtazapine , 2002 .

[24]  P. Masand,et al.  Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. , 2002, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[25]  John Cornell,et al.  A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2 , 2000, Annals of Internal Medicine.

[26]  Gerhard Rakhorst,et al.  The effects of team expert choice on group decision-making in collaborative new product development: a pilot study , 2000 .

[27]  E. Forman,et al.  Aggregating individual judgments and priorities with the analytic hierarchy process , 1998, Eur. J. Oper. Res..

[28]  L. Cunningham.  Once-Daily Venlafaxine Extended Release (XR) and Venlafaxine Immediate Release (IR) in Outpatients with Major Depression , 1997, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[29]  E. Triantaphyllou,et al.  A Sensitivity Analysis Approach for Some Deterministic Multi-Criteria Decision-Making Methods* , 1997 .

[30]  Panos M. Pardalos,et al.  On the Evaluation and Application of Different Scales For Quantifying Pairwise Comparisons in Fuzzy Sets , 1994 .

[31]  T. Saaty.  Highlights and critical points in the theory and application of the Analytic Hierarchy Process , 1994 .

[32]  R. D. Holder,et al.  Some Comments on the Analytic Hierarchy Process , 1990 .

[33]  Ward T. Smith,et al.  Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. , 1990, Psychopharmacology bulletin.

[34]  Bertrand Mareschal,et al.  Weight stability intervals in multicriteria decision aid , 1988 .

[35]  P. Harker.  Derivatives of the Perron root of a positive reciprocal matrix: With application to the analytic hierarchy process , 1987 .

[36]  M. Susser.  The epidemiology of life stress , 1981, Psychological Medicine.

[37]  Thomas L. Saaty,et al.  Multicriteria Decision Making: The Analytic Hierarchy Process: Planning, Priority Setting, Resource Allocation , 1990 .